45541
DI'AN DIAGNOSTICS GROUP CO., LTD.
Oct 11, 2021
China
East Asia and the Pacific
Nov 29, 2021
B - Limited
Active
Jun 11, 2022
Regional Industry - MAS Asia & Pac
other
Approved : Jan 18, 2022
Signed : Jan 20, 2022
Invested : May 11, 2022
other
The proposed investment will support Di’An Diagnostics Group Co., Ltd. (“Di’An”, “the Company” or “the Borrower”) to (i) expand and upgrade its existing ICL network and create 5 regional test centers through expansion of existing ICLs; (ii) add 5 “spoke” ICLs in second/third tier cities; (iii) build a manufacturing center for its self-developed In Vitro Diagnostic (“IVD”) products; (iv) fund R&D expenses to accelerate expansion in specialized testing and (v) build advanced IT infrastructure and data analytics function over the next five years (together, the “Project”). The additional testing capacity created by the Project will help to relieve capacity constraints at over-crowded public hospitals while expanding the types of testing available.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
No. 329 Jinpeng Jie, Xihu District, Hangzhou, China